Search research articles
Contact Us
Filters
Showing results (131-140 of 154) with videos related to
Page
of 16
Sort By:
Nature Medicine
|
November 9, 2019
Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease
Jennifer S Lees, Claire E Welsh, Carlos A Celis-Morales, et al.
Nature Medicine
|
July 17, 2020
Author Correction: Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease
Jennifer S Lees, Claire E Welsh, Carlos A Celis-Morales, et al.
Diabetes & Metabolic Syndrome
|
May 16, 2020
Vitamin D concentrations and COVID-19 infection in UK Biobank
Claire E Hastie, Daniel F Mackay, Frederick Ho, et al.
Circulation
|
June 25, 2021
Derivation and Validation of a 10-Year Risk Score for Symptomatic Abdominal Aortic Aneurysm: Cohort Study of Nearly 500 000 Individuals
Paul Welsh, Claire E Welsh, Pardeep S Jhund, et al.
Diabetes & Metabolic Syndrome
|
August 7, 2020
Corrigendum to "Vitamin D concentrations and COVID-19 infection in UK Biobank" [Diabetes Metabol Syndr: Clin Res Rev 2020 14 (4) 561-5]
Claire E Hastie, Daniel F Mackay, Frederick Ho, et al.
BMJ Open
|
February 2, 2019
Protocol for a multicentre randomised controlled parallel-group trial to compare the effectiveness of remotely delivered cognitive-behavioural and graded exercise interventions with usual care alone to lessen the impact of fatigue in inflammatory rheumatic diseases (LIFT)
Kathryn R Martin, Eva-Maria Bachmair, Lorna Aucott, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
April 21, 2022
Handgrip strength and all-cause dementia incidence and mortality: findings from the UK Biobank prospective cohort study
Irene Esteban-Cornejo, Frederick K Ho, Fanny Petermann-Rocha, et al.
The Lancet. Rheumatology
|
November 17, 2022
Remotely delivered cognitive behavioural and personalised exercise interventions for fatigue severity and impact in inflammatory rheumatic diseases (LIFT): a multicentre, randomised, controlled, open-label, parallel-group trial
Eva-Maria Bachmair, Kathryn Martin, Lorna Aucott, et al.
Endocrinology, Diabetes & Metabolism
|
September 10, 2021
Risk of mortality among inpatients with COVID-19 and type 2 diabetes: National data from Kuwait
Ebaa Al-Ozairi, Rosemary Brown, Yasmine Hamdan, et al.
European Journal of Preventive Cardiology
|
February 24, 2021
Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction, and estimating benefits from novel interventions
Paul Welsh, Claire Welsh, Carlos A Celis-Morales, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 154) with videos related to
Sort By:
Page
of 16
Nature Medicine
|
November 9, 2019
Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease
Jennifer S Lees, Claire E Welsh, Carlos A Celis-Morales, et al.
Nature Medicine
|
July 17, 2020
Author Correction: Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease
Jennifer S Lees, Claire E Welsh, Carlos A Celis-Morales, et al.
Diabetes & Metabolic Syndrome
|
May 16, 2020
Vitamin D concentrations and COVID-19 infection in UK Biobank
Claire E Hastie, Daniel F Mackay, Frederick Ho, et al.
Circulation
|
June 25, 2021
Derivation and Validation of a 10-Year Risk Score for Symptomatic Abdominal Aortic Aneurysm: Cohort Study of Nearly 500 000 Individuals
Paul Welsh, Claire E Welsh, Pardeep S Jhund, et al.
Diabetes & Metabolic Syndrome
|
August 7, 2020
Corrigendum to "Vitamin D concentrations and COVID-19 infection in UK Biobank" [Diabetes Metabol Syndr: Clin Res Rev 2020 14 (4) 561-5]
Claire E Hastie, Daniel F Mackay, Frederick Ho, et al.
BMJ Open
|
February 2, 2019
Protocol for a multicentre randomised controlled parallel-group trial to compare the effectiveness of remotely delivered cognitive-behavioural and graded exercise interventions with usual care alone to lessen the impact of fatigue in inflammatory rheumatic diseases (LIFT)
Kathryn R Martin, Eva-Maria Bachmair, Lorna Aucott, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
April 21, 2022
Handgrip strength and all-cause dementia incidence and mortality: findings from the UK Biobank prospective cohort study
Irene Esteban-Cornejo, Frederick K Ho, Fanny Petermann-Rocha, et al.
The Lancet. Rheumatology
|
November 17, 2022
Remotely delivered cognitive behavioural and personalised exercise interventions for fatigue severity and impact in inflammatory rheumatic diseases (LIFT): a multicentre, randomised, controlled, open-label, parallel-group trial
Eva-Maria Bachmair, Kathryn Martin, Lorna Aucott, et al.
Endocrinology, Diabetes & Metabolism
|
September 10, 2021
Risk of mortality among inpatients with COVID-19 and type 2 diabetes: National data from Kuwait
Ebaa Al-Ozairi, Rosemary Brown, Yasmine Hamdan, et al.
European Journal of Preventive Cardiology
|
February 24, 2021
Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction, and estimating benefits from novel interventions
Paul Welsh, Claire Welsh, Carlos A Celis-Morales, et al.
Page
of 16